Strategic Partnerships Leverage the exclusive U.S. market agreement with Legacy Medical Consultants to accelerate ActiGraft Pro adoption. Use this distributor partnership to access established wound care channels, hospital networks, and procurement cycles.

Autologous Advantage Position ActiGraft Pro as a personalized, patient-blood based solution for chronic wounds to differentiate from traditional bandages. Target healthcare systems and wound care centers seeking advanced, autologous therapies with potentially faster patient outcomes.

Growth Financing Financial momentum from the $26M Series D can support regional expansion, clinical demonstrations, and payer engagement. Align sales campaigns with ongoing funding to secure reimbursement discussions and ROI storytelling.

Market Readiness Capitalize on recent product launches ActiGraft Pro and ActiGraft+ to demonstrate a comprehensive wound care platform. Target hospitals, long-term care facilities, and outpatient clinics looking for integrated wound management solutions.

Industry Outreach Utilize prior conference exposure and ongoing marketing tech stack to amplify thought leadership. Equip the sales team with case studies from SAWC and AHCA/NCAL events to accelerate RFP responses and tender submissions.